Meditation and coronary heart disease: A review of the current clinical evidence

Ochsner Journal

Volumn 14, Issue 4, 2014, Pages 696-703

  Basu Ray, Indranill ^a   Menezes, Arthur R ^b   Malur, Pavan ^b   Hiltbold, Aimee E ^a   Reilly, John P ^c   Lavie, Carl J ^c,d,e  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular disease; Coronary disease; Meditation; Mind body therapies

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ANXIETY; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE THERAPY; DEPRESSION; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HEALTH EDUCATION; HOSTILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MEDITATION; MENTAL STRESS; MINDFULNESS; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SPIRITUAL HEALING; STRESS MANAGEMENT; THERAPY EFFECT; THORAX PAIN; TRANSCENDENTAL MEDITATION;

EID: 84916932360     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Goldstein JA, Chinnaiyan KM, Abidov A, et al. The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. J Am Coll Cardiol. 2011 Sep 27;58(14):1414-1422.
2. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report. 2010 Aug 6;(26):1-31.
3. Pinkstaff S, Peberdy MA, Kontos MC, Finucane S, Lavie CJ, Arena R. The influence of referral source on characteristics of patients undergoing cardiac stress testing: emergency department versus outpatient office. Postgrad Med. 2011 Mar;123(2):36-41.
4. Menezes AR, Lavie CJ, Milani RV, O’Keefe J, Lavie TJ. Psychological risk factors and cardiovascular disease: is it all in your head? Postgrad Med. 2011 Sep;123(5):165-176.
5. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Prog Cardiovasc Nurs. 2009 Mar;24(1):19-26. Republished from: Circulation. 2008 Oct 21;118(17):1768-1775.
6. Roest AM, Martens EJ, de Jonge P, Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol. 2010 Jun 29;56(1):38-46.
7. Lavie CJ, Milani RV, O’Keefe JH, Lavie TJ. Impact of exercise training on psychological risk factors. Prog Cardiovasc Dis. 2011 May-Jun;53(6):464-470.
8. Matthews KA, Gump BB, Harris KF, Haney TL, Barefoot JC. Hostile behaviors predict cardiovascular mortality among men enrolled in the Multiple Risk Factor Intervention Trial. Circulation. 2004 Jan 6;109(1):66-70.
9. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999 Apr 27;99(16): 2192-2217.
10. Ziegelstein RC, Bush DE, Fauerbach JA. Depression, adherence behavior, and coronary disease outcomes. Arch Intern Med. 1998 Apr 13;158(7):808-809.
11. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996 Oct; 153(10):1313-1317.
12. Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997 Aug 15;42(4):290-295.
13. Kaplan JR, Manuck SB, Clarkson TB, Lusso FM, Taub DM. Social status, environment, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis. 1982 Sep-Oct;2(5):359-368.
14. Yeung AC, Vekshtein VI, Krantz DS, et al. The effect of atherosclerosis on the vasomotor response of the coronary arteries to mental stress. N Engl J Med. 1991 Nov 28;325(22): 1551-1556.
15. Schwartz BG, French WJ, Mayeda GS, et al. Emotional stressors trigger cardiovascular events. Int J Clin Pract. 2012 Jul;66(7): 631-639.
16. Curtis BM, O’Keefe JH Jr. Autonomic tone as a cardiovascular risk factor: the dangers of chronic fight or flight. Mayo Clin Proc. 2002 Jan;77(1):45-54.
17. Suarez EC. Plasma interleukin-6 is associated with psychological coronary risk factors: moderation by use of multivitamin supplements. Brain Behav Immun. 2003 Aug;17(4):296-303.
18. Boltwood MD, Taylor CB, Burke MB, Grogin H, Giacomini J. Anger report predicts coronary artery vasomotor response to mental stress in atherosclerotic segments. Am J Cardiol. 1993 Dec 15;72(18):1361-1365.
19. Markovitz JH. Hostility is associated with increased platelet activation in coronary heart disease. Psychosom Med. 1998 Sep-Oct;60(5):586-591.
20. Saeed SA, Antonacci DJ, Bloch RM. Exercise, yoga, and meditation for depressive and anxiety disorders. Am Fam Physician. 2010 Apr 15;81(8):981-986.
21. Mathew KL, Whitford HS, Kenny MA, Denson LA. The long-term effects of mindfulness-based cognitive therapy as a relapse prevention treatment for major depressive disorder. Behav Cogn Psychother. 2010 Oct;38(5):561-576.
22. Goldin PR, Gross JJ. Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion. 2010 Feb;10(1):83-91.
23. Leite JR, Ornellas FL, Amemiya TM, et al. Effect of progressive self-focus meditation on attention, anxiety, and depression scores. Percept Mot Skills. 2010 Jun;110(3 Pt 1):840-848.
24. Zeidan F, Johnson SK, Gordon NS, Goolkasian P. Effects of brief and sham mindfulness meditation on mood and cardiovascular variables. J Altern Complement Med. 2010 Aug;16(8):867-873.
25. Warber SL, Ingerman S, Moura VL, et al. Healing the heart: a randomized pilot study of a spiritual retreat for depression in acute coronary syndrome patients. Explore (NY). 2011 Jul-Aug; 7(4):222-233.
26. Barnes VA, Orme-Johnson DW. Prevention and treatment of cardiovascular disease in adolescents and adults through the Transcendental Meditationt program: a research review update. Curr Hypertens Rev. 2012 Aug;8(3):227-242.
27. Dillbeck MC, Orme-Johnson DW. Physiological differences between Transcendental Meditation and rest. Am Psychol. 1987 Sep;42(9):879-881.
28. Delui MH, Yari M, Khouyinezhad G, Amini M, Bayazi MH. Comparison of cardiac rehabilitation programs combined with relaxation and meditation techniques on reduction of depression and anxiety of cardiovascular patients. Open Cardiovasc Med J. 2013 Oct 18;7:99-103.
29. Gallo LC, Roesch SC, Fortmann AL, et al. Associations of chronic stress burden, perceived stress, and traumatic stress with cardiovascular disease prevalence and risk factors in the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary Study. Psychosom Med. 2014 Jul-Aug;76(6):468-475.
30. Vaccarino V, Kondwani KA, Kelley ME, et al. Effect of meditation on endothelial function in Black Americans with metabolic syndrome: a randomized trial. Psychosom Med. 2013 Jul-Aug; 75(6):591-599.
31. Hughes JW, Fresco DM, Myerscough R, van Dulmen MH, Carlson LE, Josephson R. Randomized controlled trial of mindfulnessbased stress reduction for prehypertension. Psychosom Med. 2013 Oct;75(8):721-728.
32. Brook RD, Appel LJ, Rubenfire M, et al. Beyond medications and diet: alternative approaches to lowering blood pressure: a scientific statement from the American Heart Association. Hypertension. 2013 Jun;61(6):1360-1383.
33. Alexander CN, Langer EJ, Newman RI, Chandler HM, Davies JL. Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly. J Pers Soc Psychol. 1989 Dec;57(6):950-964.
34. Alexander CN, Barnes VA, Schneider RH, et al. A randomized controlled trial of stress reduction on cardiovascular and allcause mortality in the elderly: results of 8 and 15 year follow-ups [abstract]. Circulation. 1996;93(suppl):P629.
35. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med. 1996 Apr 8;156(7):745-752. Erratum in: Arch Intern Med. 1996 Nov 11;156(20):2302.
36. Dusseldorp E, van Elderen T, Maes S, Meulman J, Kraaij V. A meta-analysis of psychoeducational programs for coronary heart disease patients. Health Psychol. 1999 Sep;18(5):506-519.
37. Schneider RH, Alexander CN, Staggers F, et al. Long-term effects of stress reduction on mortality in persons > or¼55 years of age with systemic hypertension. Am J Cardiol. 2005 May 1;95(9): 1060-1064.
38. Schneider RH, Grim CE, Rainforth MV, et al. Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks. Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6): 750-758.
39. Jayadevappa R, Johnson JC, Bloom BS, et al. Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study. Ethn Dis. 2007 Winter;17(1):72-77. Erratum in: Ethn Dis. 2007 Summer;17(3):595.
40. Eisenberg DM, Delbanco TL, Berkey CS, et al. Cognitive behavioral techniques for hypertension: are they effective? Ann Intern Med. 1993 Jun 15;118(12):964-972.
41. Schneider RH, Staggers F, Alexander CN, et al. A randomised controlled trial of stress reduction for hypertension in older African Americans. Hypertension. 1995 Nov;26(5):820-827.
42. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens. 2008 Mar;21(3):310-316.
43. Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW. Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis. Curr Hypertens Rep. 2007 Dec;9(6):520-528.
44. Gregoski MJ, Barnes VA, Tingen MS, Harshfield GA, Treiber FA. Breathing awareness meditation and LifeSkills Training programs influence upon ambulatory blood pressure and sodium excretion among African American adolescents. J Adolesc Health. 2011 Jan;48(1):59-64.
45. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006 Jun 12;166(11):1218-1224.
46. Cooper MJ, Aygen MM. A relaxation technique in the management of hypercholesterolemia. J Human Stress. 1979 Dec;5(4):24-27.
47. Chaiopanont S. Hypoglycemic effect of sitting breathing meditation exercise on type 2 diabetes at Wat Khae Nok Primary Health Center in Nonthaburi province. J Med Assoc Thai. 2008 Jan;91(1):93-98.
48. Reynolds RM, Labad J, Strachan MW, et al. Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. J Clin Endocrinol Metab. 2010 Apr;95(4):1602-1608.
49. Michaels RR, Parra J, McCann DS, Vander AJ. Renin, cortisol, and aldosterone during transcendental meditation. Psychosom Med. 1979 Feb;41(1):50-54.
50. Walton KG, Fields JZ, Levitsky DK, Harris DA, Pugh ND, Schneider RH. Lowering cortisol and CVD risk in postmenopausal women: a pilot study using the Transcendental Meditation program. Ann N Y Acad Sci. 2004 Dec;1032:211-215.
51. Ospina MB, Bond K, Karkhaneh M, et al. Meditation practices for health: state of the research. Evid Rep Technol Assess (Full Rep). 2007 Jun;(155):1-263.